Background: There is a growing recognition of China?s role as a global health donor, in particular in Africa, but there have been few systematic studies of the level, destination, trends, or composition of these development finance flows or a comparison of China?s engagement as a donor with that of more traditional global health donors.
Author Archives: Globalization and Health
Background: We describe trends in participation by investigators from low- and middle-income countries (LMCs) in publications describing oncology randomized control trials (RCTs) over a decade.
Background: In 2008, the WHO facilitated the primary health care (PHC) revitalisation agenda.
The climate is changing and this poses significant threats to human health.
In recent years, non-communicable diseases (NCDs) have globally shown increasing impact on health status in populations with disproportionately higher rates in developing countries.
Background: Accountability in global health is a commonly invoked though less commonly questioned concept.
Background: Diabetes and its complications are a major cause of morbidity and mortality in India, and the prevalence of type 2 diabetes is on the rise.
Background: Illicit cigarettes comprise more than 11% of tobacco consumption and 17% of consumption in low- and middle-income countries.
The significance of R&D capabilities of China has become increasingly important as an emerging force in the context of globalization of pharmaceutical research and development (R&D).
Background: Development assistance for health (DAH) promotes health development in low and middle income countries.
Background: Countries of the Asia Pacific region account for a major share of the global burden of disease due to cardiovascular disease (CVD) and this burden is rising over time.
The demographic and nutritional transitions taking place in Uganda, just as in other low- and middle-income countries (LMIC), are leading to accelerating growth of chronic, non-communicable diseases (NCDs).
Background: The priorities of research funding bodies govern the research agenda, which has important implications for the provision of evidence to inform policy.
Background: The ?25×25?